Endocrinology
Medicus Pharma’s Teverelix shows positive efficacy and safety in premenopausal women
January 13, 2026Research and Development Endocrinology, Medicus Pharma, Teverelix
Medicus Pharma’s Teverelix has demonstrated long-lasting hormone suppression, as well as a favourable safety profile, in new study data. Teverelix …
University of Sheffield trial highlights immunotherapy-related improved survival rates for bladder cancer patients
January 14, 2025Research and Development Endocrinology, Oncology, Sheffield, astranzeneca, bladder cancer, immunotherapy, patients
The University of Sheffield, UK, have announced study results for its trial into the survival rates of patients with operable …
Eli Lilly shares positive results from phase 3 VIVID-1 trial of Crohn’s disease treatment
May 22, 2024Medical Communications Crohn’s disease, Eli Lilly, Endocrinology, clinical trial, mirikizumab
Eli Lilly has announced results from its pivotal phase 3 VIVID-1 study, which assessed patients with moderately to severely active …
FDA approves first treatment for liver scarring due to fatty liver disease
March 15, 2024Medical Communications Endocrinology, FDA, fatty liver disease, liver scarring, nash
The US Food and Drug Administration (FDA) has announced that it has approved Rezdiffra (resmetirom) for the treatment of adult …
Critical Path Institute receives FDA Biomarker LOS for DIPI biomarkers
June 14, 2023Research and Development Critical Path Institute, Endocrinology, FDA, biomarkers, pancreatic injury
US-based Critical Path Institute (C-Path) has announced that the Biomarker Qualification Program (BQP) at the Center for Drug Evaluation and …
